Biopromic

📍 Solna, Sweden🗓 Founded 2016👥 2 employees💰 Last funded Feb 2006
Medical Device🌐 biopromic.com
Website LinkedIn
We focus on development of rapid point-of-care diagnostics for infectious diesease detection as well as innovative reagents for diagnostic and therapeutic purposes. Our strength lies in the proprietary technologies for sample preparation, production of monoclonal antibodies targeted primarily to the carbohydrate antigens and improvement of existing technologies used in development of molecular diagnostics. Our expertise in the fields of chemistry and immunology enables us to generate a number of highly sensitive and avid monoclonal antibodies to be used in Tuberculosis diagnostics, as well as other highly pathogenic bacterial and viral diseases. We also produce a wide range of bacterial antigens or their functional analogs.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Biopromic?
Biopromic has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Biopromic last raise funding?
The most recent investment in Biopromic recorded on gritt.io was in February 2006.
When was Biopromic founded?
Biopromic was founded in 2016.
What industry is Biopromic in?
Biopromic operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Biopromic based?
Biopromic is headquartered in Solna, Sweden.